Skip to main content

Table 2 Feasibility criteria and completion rate according to each step of the trial. The results are presented according to each feasibility criterion (per treatment)

From: Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

  Target
Range
Delivered
Median (range)
STEP 01 (5 unresectable patients)
 Radiotherapy dose 49.5–55 Gy 55 Gy (55)
 Cisplatin dosage (mg/m2) 105–140 140 (105–140)
 Overall treatment time (days) < 35 29 (29–30)
STEP 02 (step 01 + 5 patients) Resectable or unresectable
 Radiotherapy dose 50–55 Gy 55 (55)
 Cisplatin dosage (mg/m2) 105–140 140 (70–140)
 Overall treatment time (days) < 35 29 (27–34)
STEP 03 (step 2 + 10 patients) Resectable or unresectable
 Radiotherapy dose 50–55 Gy 55 (55)
 Cisplatin dosage (mg/m2) 105–140 122 (70–140)
 Overall treatment time (days) < 35 29 (27–34)